Melatonin may improve sleep, quality of life in patients with breast cancer
the ONA take:
Melatonin may be a potential therapeutic agent for improve sleep and quality of life in patients with metastatic breast cancer, according to a new study published online ahead of print in the journal Supportive Care in Cancer.
Because fatigue and sleep problems are common among patients with cancer, researchers at the Sunnybrook Odette Cancer Centre in Toronto, Ontario, sought to investigate the effectiveness of melatonin at improving sleep.
For the phase 2 study, researchers enrolled 32 patients with metastatic breast cancer who were receiving hormonal or trastuzumab therapy. All participants took melatonin 5 mg at bedtime for 2 months.
Results showed that bedtime melatonin was associated with a significant improvement in subjective sleep, fatigue severity, sleep fragmentation and quantity, and quality of life.
The findings suggest that further research assessing the efficacy of melatonin for improving sleep and quality of life in patients with cancer is warranted.
Melatonin may be a potential therapeutic agent for improve sleep and quality of life in patients with metastatic breast cancer.
Sign Up for Free e-newsletters
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Follow-Up After Treatment Lacking for Younger Cancer Survivors
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|